TLSIW TriSalus Life Sciences, Inc. - Warrant
NASDAQ · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$0.85
· % 处于52周区间
· 高于低点
· 至高点
$0.4452周低点
$1.8552周高点
市值 (MRQ)
$52M
P/E (TTM)
-0.6
EPS (TTM)
$-1.31
收入 (TTM)
$45M
TLSIW 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.85
市值 (MRQ)
$52M
P/E (TTM)
-0.6
EPS (TTM)
$-1.31
收入 (TTM)
$45M
ROE (TTM)
438.3%
负债/权益 (MRQ)
5.0
52周区间
$0–$2
TLSIW 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$45M2022-12-31 → 2025-12-31
EPS$-1.842022-12-31 → 2025-12-31
自由现金流$-19M2023-12-31 → 2025-12-31
净利率-62.6%2023-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | TLSIW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -0.65年均值 ≈-0.5 | ≈-0.5 | · | · | |
| P/S (TTM) | 1.25年均值 ≈1.6 | ≈1.6 | · | · | |
| 市净率 (MRQ) | 8.05年均值 ≈-1.7 | ≈-1.7 | · | · | |
| EV / EBITDA (企业价值 / EBITDA) | -2.4 | · | · | · | |
| 股价/自由现金流 (TTM) | -2.25年均值 ≈-1.9 | ≈-1.9 | · | · | |
| 市现率 (TTM) | -2.35年均值 ≈-2.0 | ≈-2.0 | · | · | |
| EV / Revenue (市值/营收) | 1.4 | · | · | · | |
| EV / FCF (市值/自由现金流) | -3.4 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | TLSIW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 85.8%5年均值 ≈85.5% | ≈85.5% | · | · | |
| 营业利润率 (TTM) | -67.7%5年均值 ≈-158.4% | ≈-158.4% | · | · | |
| EBITDA Margin (息税折旧摊销前利润率) | -59.7%5年均值 ≈-158.4% | ≈-158.4% | · | · | |
| 税前利润率 (TTM) | -62.6%5年均值 ≈-169.3% | ≈-169.3% | · | · | |
| 净利润率 (TTM) | -62.6%5年均值 ≈-169.3% | ≈-169.3% | · | · | |
| ROA (TTM) | -54.4%5年均值 ≈-99.5% | ≈-99.5% | · | · | |
| ROE (TTM) | 438.3%5年均值 ≈182.9% | ≈182.9% | · | · | |
| ROIC | 3306.8%5年均值 ≈1121.0% | ≈1121.0% | · | · |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | TLSIW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 5.0 | · | · | · | |
| 流动比率 (MRQ) | 5.35年均值 ≈1.6 | ≈1.6 | · | · | |
| Quick Ratio (速动比率) | 2.35年均值 ≈1.2 | ≈1.2 | · | · | |
| 长期负债/股东权益 (MRQ) | 5.0 | · | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | TLSIW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 53.4%5年均值 ≈53.9% | ≈53.9% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 53.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | TLSIW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 1.55年均值 ≈1.2 | ≈1.2 | · | · | |
| Inventory Turnover (库存周转率) | 2.05年均值 ≈1.5 | ≈1.5 | · | · | |
| Receivables Turnover (应收账款周转率) | 7.85年均值 ≈7.2 | ≈7.2 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$442.7K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $45M | $29M | $19M | $12M | |
| Cost of Revenue | $7M | $4M | $3M | $2M | |
| Gross Profit | $38M | $25M | $16M | $10M | |
| R&D Expense | $15M | $18M | $30M | $21M | |
| SG&A Expense | $21M | $18M | $24M | $12M | |
| Operating Income | $-27M | $-36M | $-54M | $-36M | |
| Interest Expense | · | · | $16.0K | $1.0K | |
| Interest Income | $555.0K | $404.0K | $431.0K | $180.0K | |
| Other Non-op | $-456.0K | $-312.0K | $-378.0K | $-420.0K | |
| Pretax Income | $-39M | $-30M | $-59M | $-47M | |
| Income Tax | $7.0K | $6.0K | $9.0K | $9.0K | |
| Net Income | $-39M | $-30M | $-59M | $-47M | |
| EPS (Basic) | $-1.84 | $-1.31 | $-6.77 | $-161.55 | |
| EPS (Diluted) | $-1.84 | $-1.31 | $-6.77 | $-161.55 | |
| Shares (Basic) | 37,897,785 | 25,331,753 | 9,395,748 | 309,609 | |
| Shares (Diluted) | 37,897,785 | 25,331,753 | 9,395,748 | 309,609 | |
| EBITDA | $-27M | $-36M | $-54M | $-3M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $9M | $12M | $9M | |
| Receivables | $7M | $5M | $4M | $2M | |
| Inventory | $3M | $4M | $3M | $1M | |
| Prepaid Expense | $2M | $3M | $3M | $5M | |
| Current Assets | $32M | $21M | $21M | $17M | |
| PP&E (Net) | · | · | $2M | $2M | |
| Intangibles | · | · | $0 | $802.0K | |
| Other Non-current Assets | $418.0K | $423.0K | $466.0K | $367.0K | |
| Total Assets | $35M | $24M | $25M | $22M | |
| Accounts Payable | · | · | · | $1M | |
| Accrued Liabilities | $8M | $7M | $11M | $6M | |
| Short-term Debt | · | · | · | $944.0K | |
| Current Liabilities | $11M | $10M | $15M | $32M | |
| Capital Leases | $1M | $1M | $1M | · | |
| Total Liabilities | $69M | $50M | $52M | $34M | |
| Total Debt | $33M | $22M | · | · | |
| Common Stock | $4.0K | $3.0K | $2.0K | $0 | |
| Paid-in Capital | $297M | $254M | $222M | $10M | |
| Retained Earnings | $-331M | $-280M | $-250M | $-186M | |
| Stockholders' Equity | $-34M | $-26M | $-27M | $-177M | |
| Liabilities + Equity | $35M | $24M | $25M | $22M | |
| Shares Outstanding | 49,997,836 | 31,279,264 | 26,413,213 | 347,926 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $626.0K | $744.0K | $684.0K | $398.0K | |
| Stock-based Comp | $9M | $5M | $1M | $368.0K | |
| Amort. of Intangibles | · | · | $18.0K | $122.0K | |
| Operating Cash Flow | $-18M | $-41M | $-51M | $-32M | |
| CapEx | $918.0K | $345.0K | $588.0K | $655.0K | |
| Investing Cash Flow | $-838.0K | $-345.0K | $-2M | $-2M | |
| Stock Issued | $22M | $15M | $0 | · | |
| Stock Repurchased | · | · | · | $232M | |
| Net Stock Activity | $22M | $16M | · | $-232M | |
| Financing Cash Flow | $31M | $38M | $55M | $13M | |
| Net Change in Cash | $12M | $-3M | $2M | $-21M | |
| Taxes Paid | $16.0K | $18.0K | $14.0K | $9.0K | |
| Free Cash Flow | $-19M | $-41M | $-51M | · | |
| Levered FCF | · | · | $-51M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 84.6% | 86.1% | 85.9% | · | |
| Operating Margin | -59.7% | -122.9% | -292.5% | · | |
| Net Margin | -86.9% | -102.1% | -318.9% | · | |
| Pretax Margin | -86.9% | -102.1% | -318.9% | · | |
| EBITDA Margin | -59.7% | -122.9% | -292.5% | · | |
| ROA | -132.3% | -123.7% | -247.4% | 4.1% | |
| ROE | 147.2% | 129.7% | 669.1% | -6.6% | |
| ROIC | 3306.8% | 949.4% | 208.8% | 18.8% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.0 | 1.4 | 0.1 | |
| Quick Ratio | 2.3 | 1.3 | 1.0 | 0.1 | |
| Debt / Equity | -1.0 | -0.9 | · | · | |
| LT Debt / Equity | -1.0 | -0.9 | · | · | |
| Interest Coverage | · | · | -3384.4 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.2 | 0.8 | · | |
| Inventory Turnover | 2.0 | 1.2 | 1.3 | · | |
| Receivables Turnover | 7.8 | 6.8 | 7.2 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $-0.68 | $-0.83 | $-0.98 | · | |
| Revenue / Share | $1.19 | $1.16 | $1.97 | · | |
| Cash Flow / Share | $-0.48 | $-1.61 | $-5.33 | · | |
| Cash / Share | $0.41 | $0.27 | $0.45 | · | |
| EPS (TTM) | $-1.84 | $-1.31 | $-6.77 | $-161.55 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 53.4% | 59.0% | 49.3% | · | |
| Revenue CAGR 3Y | 53.8% | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $45M | $29M | $19M | $12M | |
| Net Income TTM | $-39M | $-30M | $-59M | $-47M | |
| Market Cap | $83M | $34M | $31M | · | |
| Enterprise Value | $96M | $48M | · | · | |
| P/E | -0.9 | -0.8 | -0.2 | -0.0 | |
| P/S | 1.8 | 1.2 | 1.7 | · | |
| P/B | -2.5 | -1.3 | -1.2 | · | |
| P / Cash Flow | -4.6 | -0.8 | -0.6 | · | |
| P / FCF | -4.4 | -0.8 | -0.6 | · | |
| EV / EBITDA | -3.5 | -1.3 | · | · | |
| EV / FCF | -5.1 | -1.2 | · | · | |
| EV / Revenue | 2.1 | 1.6 | · | · | |
| Earnings Yield | -110.8% | -119.1% | -568.9% | -215400.0% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | $9M | $13M | $12M | $11M | $9M | $8M | $7M | $7M | $6M | $6M | $5M | $5M | $3M | $3M | $4M | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $912.0K | $971.0K | $582.0K | $589.0K | $772.0K | $662.0K | $816.0K | $701.0K | |
| Gross Profit | $10M | $8M | $11M | $10M | $9M | $8M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $2M | $2M | $3M | |
| R&D Expense | $3M | $3M | $3M | $5M | $4M | $3M | $3M | $4M | $5M | $6M | $8M | $10M | $7M | $6M | $6M | $5M | |
| SG&A Expense | $5M | $5M | $4M | $7M | $6M | $5M | $5M | $5M | $4M | $5M | $6M | $9M | $5M | $4M | $8M | $3M | |
| Operating Income | $-10M | $-8M | $-3M | $-9M | $-7M | $-7M | $-8M | $-9M | $-8M | $-12M | $-14M | $-19M | $-11M | $-10M | $-27M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $877.0K | $3.0K | · | $4.0K | $4.0K | $5.0K | $1.0K | $0 | |
| Interest Income | $457.0K | $164.0K | $177.0K | $170.0K | $134.0K | $74.0K | $57.0K | $158.0K | $97.0K | $92.0K | $244.0K | $116.0K | $36.0K | $35.0K | $-240.9K | $49.0K | |
| Other Non-op | $90.0K | $-76.0K | $-71.0K | $-94.0K | $-40.0K | $-251.0K | $-102.0K | $-13.0K | $-44.0K | $-153.0K | $-321.0K | $-13.0K | $-25.0K | $-19.0K | $-7M | $-31.0K | |
| Pretax Income | $-9M | $2M | $-10M | $-11M | $-8M | $-10M | $-10M | $-2M | $-4M | $-13M | $-36M | $-1M | $-14M | $-8M | $-44M | $-8M | |
| Income Tax | $4.0K | $4.0K | $0 | $5.0K | $-3.0K | $5.0K | $-1.0K | $-3.0K | $7.0K | $3.0K | $1.0K | $0 | $13.0K | $-5.0K | $-19.2K | $0 | |
| Net Income | $-9M | $2M | $-10M | $-11M | $-8M | $-10M | $-10M | $-2M | $-4M | $-13M | $-36M | $-1M | $-14M | $-8M | $-23M | $-8M | |
| EPS (Basic) | $-0.16 | $0.03 | $-0.22 | $-0.96 | $-0.27 | $-0.39 | $-0.38 | $-0.12 | $-0.21 | $-0.60 | $29.78 | $-0.14 | $-35.84 | $-0.57 | $-79.38 | $-25.95 | |
| EPS (Diluted) | $-0.16 | $0.03 | $-0.22 | $-0.96 | $-0.27 | $-0.39 | $-0.38 | $-0.12 | $-0.21 | $-0.60 | $29.78 | $-0.14 | $-35.84 | $-0.57 | $-79.38 | $-25.95 | |
| Shares (Basic) | 58,296,711 | 51,539,682 | · | 43,057,632 | 32,899,297 | 28,527,453 | · | 26,501,597 | 23,903,659 | 23,323,045 | · | 13,173,422 | 446,287 | 16,166,581 | · | 311,823 | |
| Shares (Diluted) | 58,296,711 | 52,314,410 | · | 43,057,632 | 32,899,297 | 28,527,453 | · | 26,501,597 | 23,903,659 | 23,323,045 | · | 13,173,422 | 446,287 | 16,166,581 | · | 311,823 | |
| EBITDA | $-10M | $-8M | · | $-9M | $-7M | $-7M | · | $-9M | $-8M | $-12M | · | $-18M | $-1M | $-843.3K | · | $-432.2K |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $57M | $20M | $23M | $26M | $13M | $9M | $11M | $16M | $4M | $12M | $21M | $104.0K | $136.8K | $9M | $207.6K | |
| Receivables | $6M | $5M | $7M | $5M | $6M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | · | · | $2M | · | |
| Inventory | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | · | · | $1M | · | |
| Prepaid Expense | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $4M | $3M | $2M | $3M | $3M | $57.5K | $164.1K | $5M | $98.6K | |
| Current Assets | $60M | $68M | $32M | $33M | $38M | $25M | $21M | $24M | $28M | $13M | $21M | $29M | $161.5K | $300.9K | $17M | $306.2K | |
| PP&E (Net) | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $1M | $1M | $0 | $997.0K | · | · | $802.0K | · | |
| Other Non-current Assets | $69.0K | $69.0K | $418.0K | $419.0K | $419.0K | $424.0K | $423.0K | $424.0K | $424.0K | $424.0K | $466.0K | $367.0K | · | · | $367.0K | · | |
| Total Assets | $62M | $71M | $35M | $36M | $41M | $29M | $24M | $27M | $32M | $18M | $25M | $34M | $12M | $21M | $22M | $251M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | · | · | |
| Accrued Liabilities | $7M | $7M | $8M | $7M | $7M | $8M | $7M | $8M | $9M | $11M | $11M | $7M | · | · | $6M | · | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Current Liabilities | $11M | $12M | $11M | $11M | $9M | $12M | $10M | $10M | $12M | $14M | $15M | $9M | $6M | $5M | $32M | $2M | |
| Capital Leases | · | · | $1M | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $56M | $58M | $69M | $63M | $61M | $63M | $50M | $48M | $57M | $53M | $52M | $25M | $15M | $14M | $34M | $12M | |
| Total Debt | $33M | $33M | · | $33M | $32M | $32M | · | $22M | $21M | · | · | · | $2M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | · | $0 | · | |
| Paid-in Capital | $345M | $342M | $297M | $294M | $279M | $256M | $254M | $249M | $242M | $227M | $222M | $221M | · | · | $10M | · | |
| Retained Earnings | $-338M | $-329M | $-331M | $-321M | $-298M | $-290M | $-280M | $-269M | $-266M | $-262M | $-250M | $-213M | $-15M | $-14M | $-186M | $-12M | |
| Stockholders' Equity | $7M | $13M | $-34M | $-27M | $-19M | $-34M | $-26M | $-20M | $-24M | $-35M | $-27M | $8M | $-15M | $-14M | $-176M | $-12M | |
| Liabilities + Equity | $62M | $71M | $35M | $36M | $41M | $29M | $24M | $27M | $32M | $18M | $25M | $34M | $12M | $21M | $22M | $251M | |
| Shares Outstanding | 61,469,572 | 61,414,355 | 49,997,836 | 49,891,299 | 37,983,259 | 32,272,462 | 31,279,264 | 30,469,664 | 27,159,463 | 26,758,272 | 26,413,213 | 26,316,681 | · | · | 347,926 | · |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $136.0K | $135.0K | $126.0K | $163.0K | $165.0K | $172.0K | $193.0K | $169.0K | $181.0K | $175.0K | $194.0K | $156.0K | $150.0K | $184.0K | $-54.0K | · | |
| Stock-based Comp | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $260.0K | $68.0K | $74.0K | $117.0K | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | $0 | $13.0K | · | · | $0 | $22.0K | · | · | |
| Operating Cash Flow | $-10M | $-6M | $-2M | $-4M | $-7M | $-4M | $-6M | $-11M | $-13M | $-11M | $-9M | $-40M | $-19M | $-11M | $-8M | $-23M | |
| CapEx | $82.0K | $141.0K | $41.0K | $216.0K | $-93.0K | $754.0K | $50.0K | $169.0K | $60.0K | $66.0K | $372.0K | $178.0K | $31.0K | $7.0K | $204.0K | · | |
| Investing Cash Flow | $-82.0K | $-141.0K | $-41.0K | $-176.0K | $93.0K | $-714.0K | $-50.0K | $-169.0K | $-60.0K | $-66.0K | $-372.0K | $-9M | $130.4K | $-74.0K | $-272.0K | $-2M | |
| Stock Issued | $0 | $43M | $-211.0K | $0 | $22M | $0 | $3M | $6M | $4M | $3M | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $43M | · | · | · | $0 | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $-54.0K | $42M | $277.0K | $82.0K | $21M | $10M | $3M | $6M | $26M | $3M | $43.0K | $62M | $13M | $8M | $6M | $7M | |
| Net Change in Cash | $-10M | $36M | $-2M | $-4M | $13M | $4M | $-3M | $-5M | $13M | $-8M | $-10M | $12M | $-5M | $-3M | $-3M | $-18M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $15.0K | $1.0K | $14.0K | $0 | $4.0K | $0 | · | · | · | · | $-47.0K | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-5M | · | · | · | $-11M | · | · | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.8% | 86.2% | · | 83.5% | 83.9% | 83.7% | · | 86.3% | 87.6% | 85.0% | · | 88.7% | · | · | · | · | |
| Operating Margin | -86.0% | -94.5% | · | -77.9% | -65.4% | -80.0% | · | -118.9% | -111.0% | -181.0% | · | -355.8% | · | · | · | · | |
| Net Margin | -80.5% | 17.3% | · | -93.5% | -73.9% | -113.2% | · | -32.6% | -58.8% | -204.7% | · | -24.8% | · | · | · | · | |
| Pretax Margin | -80.5% | 17.3% | · | -93.4% | -73.9% | -113.1% | · | -32.7% | -58.7% | -204.7% | · | -24.8% | · | · | · | · | |
| EBITDA Margin | -86.0% | -94.5% | · | -77.9% | -65.4% | -80.0% | · | -118.9% | -111.0% | -181.0% | · | -355.8% | · | · | · | · | |
| ROA | -17.7% | 3.1% | · | -33.8% | -22.5% | -44.6% | · | -7.9% | -19.4% | -68.8% | · | -0.90% | -0.76% | -0.33% | · | 0.26% | |
| ROE | 142.7% | -14.3% | · | 45.9% | 38.0% | 29.9% | · | 40.2% | 22.1% | 54.2% | · | 81.1% | 7.5% | 3.2% | · | -4.2% | |
| ROIC | -24.8% | -18.3% | · | -149.3% | -57.0% | 274.5% | · | -701.6% | 286.0% | 33.5% | · | -217.7% | 11.0% | 6.5% | · | 2.9% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.8 | · | 3.1 | 4.1 | 2.1 | · | 2.4 | 2.3 | 0.9 | · | 3.1 | 0.0 | 0.1 | · | 0.2 | |
| Quick Ratio | 4.7 | 5.2 | · | 2.5 | 3.4 | 1.6 | · | 1.6 | 1.8 | 0.6 | · | 2.6 | 0.0 | 0.0 | · | 0.1 | |
| Debt / Equity | 5.0 | 2.6 | · | -1.2 | -1.7 | -0.9 | · | -1.1 | -0.9 | · | · | · | -0.1 | · | · | · | |
| LT Debt / Equity | 5.0 | 2.6 | · | -1.2 | -1.7 | -0.9 | · | -1.1 | -0.9 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -9.3 | -3895.0 | · | -4619.2 | · | · | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.4 | 0.3 | 0.4 | · | 0.2 | 0.3 | 0.3 | · | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.4 | 0.3 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.7 | · | 0.7 | · | · | · | · | |
| Receivables Turnover | 1.9 | 1.7 | · | 2.3 | 2.2 | 1.9 | · | 1.8 | 3.1 | 3.0 | · | 3.4 | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.11 | $0.21 | · | $-0.54 | $-0.51 | $-1.06 | · | $-0.67 | $-0.89 | $-1.31 | · | $0.32 | · | · | · | · | |
| Revenue / Share | $0.20 | $0.17 | · | $0.27 | $0.34 | $0.32 | · | $0.28 | $0.31 | $0.28 | · | $0.39 | · | · | · | · | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.16 | · | · | · | $-0.47 | · | · | · | · | · | · | |
| Cash / Share | $0.75 | $0.92 | · | $0.45 | $0.70 | $0.40 | · | $0.37 | $0.61 | $0.15 | · | $0.81 | · | · | · | · | |
| EPS (TTM) | $-1.31 | $-1.42 | · | $-2.00 | $-1.16 | $-1.10 | · | $28.85 | $28.83 | $-6.80 | · | $-115.93 | $-141.74 | · | · | · |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45M | $45M | · | $40M | $36M | $32M | · | $27M | $25M | $22M | · | $16M | $15M | · | · | · | |
| Net Income TTM | $-28M | $-27M | · | $-40M | $-31M | $-27M | · | $-56M | $-55M | $-64M | · | $-46M | $-53M | $-48M | · | $-22M | |
| Market Cap | $49M | $74M | · | $85M | $49M | $39M | · | $31M | $44M | $27M | · | $10M | · | · | · | · | |
| Enterprise Value | $36M | $50M | · | $95M | $55M | $58M | · | $41M | $49M | · | · | · | · | · | · | · | |
| P/E | -0.6 | -0.8 | · | -0.8 | -1.1 | -1.1 | · | 0.0 | 0.1 | -0.1 | · | -0.0 | -0.0 | · | · | · | |
| P/S | 1.1 | 1.6 | · | 2.1 | 1.4 | 1.2 | · | 1.1 | 1.8 | 1.2 | · | 0.6 | · | · | · | · | |
| P/B | 7.5 | 5.8 | · | -3.2 | -2.5 | -1.1 | · | -1.5 | -1.8 | -0.8 | · | 1.2 | · | · | · | · | |
| P / Tangible Book | 7.5 | 5.8 | · | · | · | · | · | · | · | · | · | 1.3 | · | · | · | · | |
| P / Cash Flow | · | -11.4 | · | · | · | -8.7 | · | · | · | -2.5 | · | · | · | · | · | · | |
| EV / Revenue | 0.8 | 1.1 | · | 2.4 | 1.5 | 1.8 | · | 1.5 | 2.0 | · | · | · | · | · | · | · | |
| Earnings Yield | -163.8% | -118.3% | · | -117.7% | -89.9% | -90.9% | · | 2856.4% | 1768.7% | -680.0% | · | -30507.9% | -337476.2% | · | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $45M | $29M | $19M | $12M | · |
| 毛利率 % | 84.6% | 86.1% | 85.9% | · | · |
| 营业利润率 % | -59.7% | -122.9% | -292.5% | · | · |
| 净收入 | $-39M | $-30M | $-59M | $-47M | $5M |
| 稀释后每股收益 (EPS) | $-1.84 | $-1.31 | $-6.77 | $-161.55 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | -1.0 | -0.9 | · | · | · |
| 流动比率 | 2.8 | 2.0 | 1.4 | 0.1 | · |
| 速动比率 | 2.3 | 1.3 | 1.0 | 0.1 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-19M | $-41M | $-51M | · | · |
机构持有人 (13F) 6 家申报者 · $1.8M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
6
持有价值
$1.8M
新仓位
0
已退出持仓
2
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 0 (-1 与上一季度对比) | 2 (0 与上一季度对比) | 1 (0 与上一季度对比) | 0 (-2 与上一季度对比) | -19K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| JNB Advisors LLC | $1075867 | 827590 | 59.12% | 股份 |
| Cerity Partners LLC | $662072 | 827590 | 36.38% | 股份 |
| ARISTEIA CAPITAL, L.L.C. | $56872 | 74826 | 3.13% | 股份 |
| Fort Baker Capital Management LP | $21100 | 26374 | 1.16% | 股份 |
| TORONTO DOMINION BANK | $3929 | 5170 | 0.22% | 股份 |
| Vestcor Inc | $54 | 70832 | 0.00% | 股份 |
公司内部人士 4 位内幕人士 · 4 位高管 · 1 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Mary T Szela | CEO and President | 2026年6月30日 A | 1077683 | 0 | 0 | $0 |
| David Patience | Chief Financial Officer | 2026年7月1日 F | 261107 | 0 | 0 | $0 |
| Richard Marshak | Chief Commercial Officer | 2026年6月30日 A | 128319 | 0 | 0 | $0 |
| Richard Henry Marshall | Chief Medical Officer | 2026年6月29日 A | 90000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报